August 31, 2021
UC San Diego researchers developed first-of-their-kind lung organoids that include all cell types that make up the organ, allowing for “Phase 0” testing of new treatments for respiratory infections such as COVID-19.
September 10, 2014
Napoleone Ferrara, MD, Distinguished Professor of Pathology and Distinguished Adjunct Professor of Ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the António Champalimaud Vision…
January 28, 2020
University of California San Diego School of Medicine researchers created a new type of brain cancer model for glioblastoma using stem cells, CRISPR and gene sequencing.
May 10, 2024
New insights into the metabolism of autism from researchers at UC San Diego could help inform early detection and prevention strategies for the disorder.
October 17, 2017
Two recent studies led by UC San Diego biologists have set the research groundwork for new avenues to treat influenza and anthrax poisoning. Published in PLOS Pathogens, the studies from Professor Ethan Bier’s laboratory used a series of experiments to identify key pathways and mechanisms previously unknown or overlooked in…
April 24, 2013
Biologists at UC San Diego have identified eight genes never before suspected to play a role in wound healing that are called into action near the areas where wounds occur.
October 13, 2022
The University of California San Diego today announced the 2022 recipients of the Revelle Medal, which recognizes current and former faculty members for sustained, distinguished and extraordinary service to the university.
November 7, 2018
…in the cell eventually could lead to developing new drugs for fighting diseases like cancer.
January 22, 2015
Upending decades-old dogma, a team of scientists at the University of California, San Diego School of Medicine say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.
April 19, 2021
Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them.
